Today: 2 July 2026
Browse Category

NASDAQ:MSTR 8 July 2025 - 22 September 2025

Bitcoin vs Ethereum 2025: The Ultimate Crypto Investment Showdown 🚀💰

Bitcoin vs Ethereum 2025: The Ultimate Crypto Investment Showdown 🚀💰

Bitcoin: 2025 has been a landmark year for Bitcoin’s price. Following the April 2024 halving, Bitcoin showed resilience and entered 2025 with bullish momentum. By late 2025, Bitcoin hit all-time highs, trading around $117,000 – a dramatic climb from prior years nasdaq.com. Year-to-date, BTC is up roughly 24% nasdaq.com despite intermittent pullbacks. Bitcoin’s rally has been steadier and less turbulent compared to Ethereum’s swings, reinforcing its reputation as the more stable of the two majors. Part of Bitcoin’s strength is its status as a macroeconomic hedge – it’s often called “digital gold” because during times of financial stress or inflation, investors flock to BTC as a store of value nasdaq.com. For example, a BlackRock analysis found Bitcoin has “lived up to its billing as a safe asset,” eventually outperforming gold in the aftermath of shocks like the 2020 COVID crash nasdaq.com. This safe-haven appeal helped Bitcoin retain value through 2025’s market fluctuations. Ethereum: Ethereum’s price journey in 2025 has been more volatile. After a strong 2024, Ethereum initially stumbled, dropping nearly 50% from its highs by early 2025 vaneck.com. By March 2025, ETH was significantly underperforming BTC. However, that narrative flipped dramatically in Q2: within a single week in April,
Bitcoin Whale Dumps $9B, Altcoins Whipsaw, NFTs Boom and Regulators Swoop – Crypto News Roundup (July 25–26, 2025)

Bitcoin Whale Dumps $9B, Altcoins Whipsaw, NFTs Boom and Regulators Swoop – Crypto News Roundup (July 25–26, 2025)

Bitcoin dipped below $115,000 overnight on the whale’s massive transfers, but rebounded above $117,000 after asset manager Galaxy confirmed it had completed the sale on the whale’s behalf as part of estate planning coindesk.com coindesk.com. With that selling pressure cleared, analysts suggested the local bottom was likely in – Ledn’s John Glover predicted Bitcoin could soon resume its uptrend, “rallying to circa $132,000” in the next wave coindesk.com. Even after the week’s volatility, BTC is roughly $117K, down about 1–2% on the day and 3% below its mid-week peak of $120K coindesk.com. Traders noted that macroeconomic signals contributed to the pullback – stronger U.S. jobs data cooled hopes for Fed rate cuts, prompting a broad risk-off move that dragged Bitcoin to two-week lows around $114.7K ainvest.com ainvest.com. Ethereum held up relatively well despite the turbulence. After surging nearly 50% in July amid bullish technicals and record fund inflows, ETH hovered near $3,700 going into the weekend coindesk.com. In fact, Ethereum-focused investment products have seen a historic rush of capital – U.S. spot ETH ETFs attracted $4.6B of inflows in just the past two weeks, pushing total assets to ~$10B coindesk.com coindesk.com. BlackRock’s Ethereum fund hit the $10B milestone faster than
Bitcoin Blasts Past $120K as Wall Street Embraces Crypto – July 2025’s Must-Read Blockchain Roundup

Bitcoin Blasts Past $120K as Wall Street Embraces Crypto – July 2025’s Must-Read Blockchain Roundup

Bitcoin Hits All-Time Highs: July 2025 saw Bitcoin surge to unprecedented levels, breaching the $120,000 mark for the first time. By late month, Bitcoin traded around $123,000 en.cryptonomist.ch, cementing its status as one of 2025’s top-performing assets. The broader crypto market followed suit – total crypto market capitalization blew past the $4 trillion milestone for the first time ever en.cryptonomist.ch. Analysts credited a confluence of bullish factors, from clearer U.S. regulations to a wave of institutional buying, for driving this historic rally en.cryptonomist.ch en.cryptonomist.ch. Not everyone was euphoric, however. Financial author Robert Kiyosaki stirred debate by warning that the Bitcoin “bubble” could “burst” soon, even as he had previously cheered its record highs newsletter.coinpaper.com. His contrarian stance highlighted lingering caution in some corners amid the frenzy. Ethereum and Altcoins Climbed: Ethereum rode the bullish wave too – ETH jumped above $3,700 en.cryptonomist.ch, benefiting from network improvements and growing DeFi activity. In fact, Ethereum’s major mid-year “Pectra” upgrade has started paying dividends, lowering transaction fees and streamlining staking on the network ainvest.com coindesk.com. Among top altcoins, Solana enjoyed renewed optimism: SOL hovered around the mid-$150s in July cointelegraph.com, buoyed by technological strides and the debut of a first-of-its-kind Solana staking ETF.
June–July 2025 Blockchain & DLT Developments: Major News, Trends, Regulation, and Adoption

June–July 2025 Blockchain & DLT Developments: Major News, Trends, Regulation, and Adoption

June and early July 2025 were exceptionally eventful for blockchain and distributed ledger technology. The period saw landmark corporate milestones, surging institutional interest, major regulatory moves, and growing real-world adoption across sectors. “June proved to be a powerhouse month for the crypto world,” with record investment inflows, a blockbuster stablecoin company IPO, new stablecoin launches, and key legislation, signaling that blockchain is increasingly mainstream ccn.com. Below is a detailed report of the notable news, industry forecasts, regulatory updates, innovations, expert commentary, and adoption trends during June and July 2025. Major developments in this period included unprecedented market debuts, strategic expansions by exchanges, and fintech forays into digital assets:
1 12 13 14

Stock Market Today

  • Cramer Sees Moderna's Pipeline Opening Up Beyond Covid
    July 1, 2026, 7:50 PM EDT. CNBC's Jim Cramer said on Mad Money that Moderna now looks different than during the Covid rush, with a cancer pipeline and vaccines reaching outside infectious diseases. He sees many programs still years out but calls for buying pullbacks, pointing to Moderna's track to profits and new data from late-stage cancer trials-like the melanoma combo trial with Merck's Keytruda. Moderna shares have jumped almost 150% this year but still trade under pandemic highs. Cramer also mentions fresh regulatory wins, including FDA advisory backing for its flu shot and a European nod for its combined Covid-flu vaccine.
Go toTop